Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Medicus Sciences Acquisition Corp.
|
|
| Income Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-22 | Mar-31-22 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| | 10-Q | 10-Q | 10-Q/A | 10-Q | 10-Q |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Gross profit | -0.2 | -0.2 | -0.2 | -0.2 | -0.1 |
| Other operating expenses | -1.6 | -2.4 | -2.4 | | |
| EBIT [+] | 1.4 | 2.2 | 2.3 | -0.2 | -0.1 |
| EBIT growth | -840.7% | -2142.1% | | | |
| Non-recurring items | 1.6 | 2.4 | 2.4 | | |
| Interest income | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest income | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other income (expense), net [+] | 1.7 | 2.5 | 2.4 | -1.4 | 1.6 |
| Change in fair value of warrants | 1.7 | 2.5 | 2.4 | -1.4 | 1.8 |
| Pre-tax income | 1.6 | 2.3 | 2.3 | -1.5 | 1.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 1.6 | 2.3 | 2.3 | -1.5 | 1.4 |
| |
| Basic EPS [+] | $0.14 | $0.19 | $0.19 | ($0.13) | $0.23 |
| Growth | -201.7% | -14.3% | | | |
| Diluted EPS [+] | $0.14 | $0.19 | $0.19 | ($0.13) | $0.23 |
| Growth | -201.7% | -14.3% | | | |
| |
| Shares outstanding (basic) [+] | 11.6 | 11.6 | 11.6 | 11.6 | 6.4 |
| Growth | 0.0% | 81.7% | | | |
| Shares outstanding (diluted) [+] | 11.6 | 11.6 | 11.6 | 11.6 | 6.4 |
| Growth | 0.0% | 81.7% | | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|